Negative association between 25-hydroxyvitamin D and inflammatory markers in rheumatologic diseases

Brance, María Lorena; Larroudé, María Silvia; Berbotto, Guillermo; Sacnun, Mónica P; Aeschlimann, Carolina; Palatnik, Mariano; Chavero, Ignacio; Sánchez, Ariel; Brun, Lucas R.
Actual. osteol ; 17(1): 8-17, 2021. graf, tab
Artículo en Inglés | LILACS, UNISALUD, BINACIS | ID: biblio-1291888

Documentos relacionados

  1. Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial.
  2. Associations of serum 25-hydroxyvitamin D with circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism.
  3. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
  4. How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? a placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D3 every 3 months in elderly women.
  5. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
  6. Bioavailability and Safety of Vitamin D3 from Pizza Baked with Fortified Mozzarella Cheese: A Randomized Controlled Trial.
  7. Phosphocalcic metabolism and its potential association with biomarkers of kidney disease in dogs with spontaneous hyperadrenocorticism.
  8. Effect of a plant protein-rich diet on postprandial phosphate metabolism in healthy adult men: a randomised controlled trial.
  9. Factors influencing pre-operative urinary calcium excretion in primary hyperparathyroidism.
  10. The Effect of Short-Term Vitamin D Supplementation on Calcium Status in Vitamin D Insufficient Renal Transplant Recipients at Risk of Hypercalcemia.